White label ELPA - ClinicalTrials.eu

Study of fludarabine phosphate in patients with blood cancer undergoing lymphodepletion before CAR-T cell therapy

Recruiting

3 1 1 1
Investigated Diseases:
- Haematological malignancy
Investigated Drugs:
A study of ACR-368 and gemcitabine for patients with endometrial cancer

Recruiting

2 1 1 1
Investigated Drugs:
- Gemcitabine
Study of zenagamtide for weight loss and sleep improvement in patients with obesity and obstructive sleep apnea using positive airway pressure therapy

Recruiting

3 1
Investigated Diseases:
- Obstructive sleep apnoea syndrome
Study of inavolisib, ribociclib, and fulvestrant for patients with advanced hormone-receptor-positive, HER2-negative breast cancer.

Recruiting

2 1 1
Investigated Drugs:
A study of rilvegostomig, cisplatin, and gemcitabine compared to durvalumab and a drug combination for adults with advanced biliary tract cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Bile duct cancer
Investigated Drugs:
+1
A study of mRNA-4157 and a drug combination for patients with stage IV non-small cell lung cancer

Recruiting

2 1 1
Investigated Drugs:
A study to evaluate the effectiveness and safety of NBI-1117570 in adults with schizophrenia who require hospital treatment.

Recruiting

2 1
Investigated Drugs:
- HTL0022537
Safety of injecting bupivacaine and dexamethasone into the parotid gland for patients undergoing surgery for a benign parotid tumor

Recruiting

2 1 1 1
Investigated Diseases:
- Salivary gland cancer
Investigated Drugs:
A study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis

Recruiting

2 1
A study to evaluate the effects of CSX-1004 on breathing difficulties caused by fentanyl in healthy adults and people with opioid use disorder

Recruiting

2 1 1
Investigated Diseases:
- Drug use disorder
Investigated Drugs:
- Sodium Chloride

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies